BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Santis A, Moscatelli R, Catalano C, Iannetti A, Gigliotti F, Cristofari F, Trapani S, Attili AF. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study. Dig Liver Dis. 2010;42:451-455. [PMID: 19819770 DOI: 10.1016/j.dld.2009.08.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Gao F, Wang L, Pan J, Yin Y, Wang J, Xu X, Xu S, Mancuso A, Qi X. Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta-analysis. J Intern Med 2022. [PMID: 36208172 DOI: 10.1111/joim.13575] [Reference Citation Analysis]
2 Huang X, Zhang M, Ai Y, Jiang S, Xiao M, Wang L, Jian Y, Zhuge Y, Zhang C, Chen S. Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Ther Adv Chronic Dis 2022;13:20406223221125691. [PMID: 36172080 DOI: 10.1177/20406223221125691] [Reference Citation Analysis]
3 Gao FB, Wang L, Zhang WX, Shao XD, Guo XZ, Qi XS. Successful treatment of acute symptomatic extensive portal venous system thrombosis by 7-day systemic thrombolysis. World J Gastrointest Surg 2022; 14(9): 1082-1085 [DOI: 10.4240/wjgs.v14.i9.1082] [Reference Citation Analysis]
4 Ahmed T, Grigorian AY, Messerli AW. Management of Acute Coronary Syndrome in Patients with Liver Cirrhosis. Am J Cardiovasc Drugs 2022;22:55-67. [PMID: 34050893 DOI: 10.1007/s40256-021-00478-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kotsifa E, Kykalos S, Machairas N, Nikiteas N, Sotiropoulos GC. Management of portal vein thrombosis in cirrhotic patients enlisted for liver transplantation: From diagnosis to treatment (Review). Biomed Rep 2021;15:94. [PMID: 34631049 DOI: 10.3892/br.2021.1470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Oguslu U, Uyanik SA, Cenkeri HÇ, Atli E, Yilmaz B, Gümüş B. Transhepatic Pharmacomechanical Thrombectomy of Symptomatic Acute Noncirrhotic, Nonmalignant Portomesenteric Venous Thrombosis: Midterm Results. AJR Am J Roentgenol 2021;217:418-25. [PMID: 34036807 DOI: 10.2214/AJR.20.23150] [Reference Citation Analysis]
8 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021;22:176-86. [PMID: 33470535 DOI: 10.1111/1751-2980.12970] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
9 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
10 Lemma A, Åberg F, Mäkisalo H, Vikatmaa P, Mentula P, Leppäniemi A, Sallinen V. Predictors of insufficient recanalization and portal hypertensive complications after treatment of non-cirrhotic, non-malignant portal vein thrombosis - a population-based study. Scand J Gastroenterol 2020;55:1324-32. [PMID: 32976739 DOI: 10.1080/00365521.2020.1823465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sarmiento Burbano WA, Otero Regino W, Parga Bermúdez JE. Trombosis venosa portal posesplenectomía por anemia hemolítica. Reporte de caso y revisión de la literatura. Rev Colomb Gastroenterol 2019;34:91. [DOI: 10.22516/25007440.358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Senzolo M, Riva N, Dentali F, Rodriguez-Castro K, Sartori MT, Bang SM, Martinelli I, Schulman S, Alatri A, Beyer-Westendorf J, Di Minno MND, Ageno W; IRSVT study investigators. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis. Clin Transl Gastroenterol. 2018;9:176. [PMID: 30108204 DOI: 10.1038/s41424-018-0043-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
13 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 16.4] [Reference Citation Analysis]
14 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
15 Trifan A, Stanciu C, Girleanu I. Portal Vein Thrombosis in Patients with Liver Cirrhosis. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Mancuso A. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Curr Hepatology Rep 2017;16:158-63. [DOI: 10.1007/s11901-017-0344-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Artaza T, Lopes M, Romero M, Sánchez JJ, De la Cruz G, González C, Gómez R. Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment. EMJ Hepatol 2016. [DOI: 10.33590/emjhepatol/10311905] [Reference Citation Analysis]
19 Wang CY, Ren JZ, Han XW, Zhang WG, Zhang QH, Chen PF, Zhao GR. Clinical efficacy of agitation thrombolysis via transjugular access for treatment of acute portal vein thrombosis. Shijie Huaren Xiaohua Zazhi 2016; 24(14): 2225-2230 [DOI: 10.11569/wcjd.v24.i14.2225] [Reference Citation Analysis]
20 Chamarthy MR, Anderson ME, Pillai AK, Kalva SP. Thrombolysis and Transjugular Intrahepatic Portosystemic Shunt Creation for Acute and Subacute Portal Vein Thrombosis. Tech Vasc Interv Radiol. 2016;19:42-51. [PMID: 26997088 DOI: 10.1053/j.tvir.2016.01.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
21 Lorenz JM, Patel MV. Management of Early Post-transplant Portal Vein Thrombosis: Results of Interventional Techniques Versus Surgical. Difficult Decisions in Surgery: An Evidence-Based Approach 2016. [DOI: 10.1007/978-3-319-27365-5_32] [Reference Citation Analysis]
22 Harding DJ, Perera MTP, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21(22): 6769-6784 [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 71] [Article Influence: 9.0] [Reference Citation Analysis]
23 Intagliata NM, Henry ZH, Northup PG. Portal Vein Thrombosis in Patients with Cirrhosis—Etiology, Diagnosis, and Management. Curr Hepatology Rep 2015;14:1-8. [DOI: 10.1007/s11901-015-0249-7] [Reference Citation Analysis]
24 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 13.6] [Reference Citation Analysis]
25 Valla D. Portal Vein Thrombosis. Complications of Cirrhosis 2015. [DOI: 10.1007/978-3-319-13614-1_20] [Reference Citation Analysis]
26 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
27 Nery F, Valla D. Splanchnic and Extrasplanchnic Thrombosis in Cirrhosis: Prophylaxis vs Treatment. Curr Hepatology Rep 2014;13:224-234. [DOI: 10.1007/s11901-014-0233-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 2014;11:435-46. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 12.3] [Reference Citation Analysis]
29 Raja K, Jacob M, Asthana S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol 2014;4:320-31. [PMID: 25755579 DOI: 10.1016/j.jceh.2013.12.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
30 Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Okabe S, Yoshikawa M, Yokosuka O. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan. Hepatol Int 2013;7:1030-9. [DOI: 10.1007/s12072-013-9470-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
31 Seijo S, García-criado Á, Darnell A, García-pagán JC. Diagnóstico y tratamiento de la trombosis portal en la cirrosis hepática. Gastroenterología y Hepatología 2012;35:660-6. [DOI: 10.1016/j.gastrohep.2012.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012;57:203-12. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 159] [Cited by in F6Publishing: 163] [Article Influence: 15.9] [Reference Citation Analysis]
33 Rodriguez-castro KI, Simioni P, Burra P, Senzolo M. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int 2012;32:1465-76. [DOI: 10.1111/j.1478-3231.2012.02839.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
34 Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011;54:78-88. [PMID: 20932597 DOI: 10.1016/j.jhep.2010.06.029] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 14.9] [Reference Citation Analysis]